AMZN
Amazon.com, Inc.
AMZN has the edge over CHH overall, supported by stronger modeled upside and stronger valuation.
CHH
Choice Hotels International, Inc.
CHH trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CHH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Weak |
CHH's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is weak.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over CHH in the historical PE scenario, which offers more potential upside but is not a forecast.
CHH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $73.78 | -38% |
| Forward | 16x | $118 | — |
| Fair | 21x | $95.93 | -19% |
| Current | 26x | $118 | — |
| Expensive | 35x | $155 | +31% |
Historical ranges are pointers, not guarantees.
CHH's PE is in its fair range at 26x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
CHH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CHH, but weaker profitability.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over CHH on earnings, with more consistent year-over-year improvement.
CHH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.52 | +68% |
| Q3 2026 | $4.48 | -45% |
| Q2 2026 | $7.06 | +9.1% |
| Q1 2026 | $7.40 | +13% |
| Q4 2025 | $7.90 | +27% |
| Q3 2025 | $8.11 | +55% |
| Q2 2025 | $6.47 | +34% |
| Q1 2025 | $6.52 | +40% |
| Q4 2024 | $6.20 | +22% |
CHH's earnings per share have fallen from their peak: $4.48 over the past year, against $8.11 in late 2025.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over CHH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
CHH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $458.3M | +2.5% |
| Q2 2026 | $440.8M | +3.4% |
| Q1 2026 | $340.6M | +2.3% |
| Q4 2025 | $390.2M | +0.1% |
| Q3 2025 | $447.3M | +4.5% |
| Q2 2025 | $426.4M | -2% |
| Q1 2025 | $332.9M | +0.3% |
| Q4 2024 | $389.8M | +8.8% |
CHH's revenue grew through 2023 and has held roughly level since: $458M last quarter, up 2.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | -8.6 points |
| Q2 2026 | 24% | -5.6 points |
| Q1 2026 | 18% | -6.4 points |
| Q4 2025 | 26% | -4.6 points |
| Q3 2025 | 32% | -3.6 points |
| Q2 2025 | 29% | -1.3 points |
| Q1 2025 | 24% | +5.9 points |
| Q4 2024 | 31% | +20 points |
CHH has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
CHH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $44.3M | -9.7% |
| Q2 2026 | $80.1M | +22% |
| Q1 2026 | -$40M | -$25M |
| Q4 2025 | $64.1M | +12% |
| Q3 2025 | $49.1M | -70% |
| Q2 2025 | $65.4M | -8% |
| Q1 2025 | -$15M | +$16M |
| Q4 2024 | $57.4M | +296% |
CHH has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
CHH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -317K shares |
| 1 year | -3% | -1.4M shares |
| 3 years | -11% | -5.4M shares |
| 5 years | -19% | -10.8M shares |
| Available history | -19% | -10.6M shares |
CHH has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $58.7M |
| Q2 2026 | $51M |
| Q1 2026 | $56.5M |
| Q4 2025 | $25.3M |
| Q3 2025 | $202,000 |
| Q2 2025 | $48.1M |
| Q1 2025 | $64.6M |
| Q4 2024 | $31.8M |
CHH spent $192M buying back its own shares over the past year, up 32% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over CHH on leverage, with a lower net debt burden relative to earnings.
CHH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.6x | High |
| Q2 2026 | 4.1x | High |
| Q1 2026 | 4.0x | Elevated |
| Q4 2025 | 3.7x | Elevated |
| Q3 2025 | 3.6x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 3.5x | Elevated |
| Q4 2024 | 3.4x | Elevated |
CHH's net debt is about 4.6 years of its operating earnings (EBITDA), up from 3.6 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
CHH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.3 | Neutral |
| Stochastic | 83.8 | Overbought |
CHH's weekly RSI is 62 (neutral) and its Stochastic is 84 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over CHH on valuation relative to its sector.
CHH PE vs Consumer Cyclical Sector
| Metric | CHH | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 18x | 47% above |
| PE % | 65 | 47 | 18 pts above |
CHH is trading at 26x earnings, a 47% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over CHH on trend strength, trading above more of its moving averages.
CHH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $109.4 | 8.1% above |
| 20 week MA | $107.8 | 9.8% above |
| 50 week MA | $106.2 | 11% above |
| 100 week MA | $115.5 | 2.5% above |
| 200 week MA | $119.2 | 0.8% below |
CHH has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 0.8% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
CHH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $104.9 | $104.1 | -0.8% |
| 2021 | $104.1 | $152.7 | +47% |
| 2022 | $152.7 | $112.2 | -27% |
| 2023 | $112.2 | $113.3 | +1% |
| 2024 | $113.3 | $140.8 | +24% |
| 2025 | $140.8 | $96.0 | -32% |
| 2026 YTD | $96.0 | $118.3 | +23% |
CHH has the edge over AMZN on returns for 2026, with the stronger performance.